Law & Practice

DENMARK: De-Branding of Parallel Imported Medicines Determined to Be Legal

Published: June 18, 2025

Rachel Cockburn Buhl

Rachel Cockburn Buhl Ferring Pharmaceuticals Copenhagen, Denmark Parallel Imports Committee

David Degen Novartis Pharma AG Basel, Switzerland Parallel Imports Committee

Verifier

Nina Ringen

Nina Ringen Bruun & Hjejle Copenhagen, Denmark INTA Bulletins—Europe Subcommittee

This page is accessible only to INTA members.

Log In     Join INTA

Free Trial Membership

Take advantage of a 21-day free trial membership to access exclusive member-only content. See details

*Required. By clicking “Request Trial Membership,” I agree to INTA’s Privacy Policy and website Terms of Use. No credit card or billing information required.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.